Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00589654 · ClinicalTrials.gov registry record

Menstrual Cycle Maintenance and Quality of Life: A Prospective Study

A clinical trial of Breast Cancer and Amenorrhea, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
810
Enrollment target
1
Study location

NCT00589654 is a study of Breast Cancer and Amenorrhea that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 810 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00589654, a study of Breast Cancer and Amenorrhea, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
810 participants
Enrollment target
1
Study location

Study Summary

Very little is known about the incidence, onset, time course, and symptomatology of premature menopause induced by breast cancer therapy. No prospective study exists. The purpose of the present study is to identify determinants of treatment-related amenorrhea nad its effect on quality of life in a cohort of youg breast cancer patients.

Interventions

  • OTHER Questionnaire

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 810 participants
Start Date 1997-12
Est. Completion 2026-12

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00589654

The ClinicalTrials.gov registry entry for NCT00589654 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 810 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (71% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.

NCT00589654 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00589654 about?

NCT00589654 is a clinical study titled "Menstrual Cycle Maintenance and Quality of Life: A Prospective Study". Very little is known about the incidence, onset, time course, and symptomatology of premature menopause induced by breast cancer therapy. No prospective study exists. The purpose of the present study is to identify determinants of treatment-related amenorrhea nad its effect on quality of life in a c...

What is the current status of trial NCT00589654?

This trial is currently active not recruiting. The enrollment target is 810 participants. The study started on 1997-12. Estimated completion is 2026-12.

What conditions does trial NCT00589654 study?

This clinical trial studies the following conditions: Breast Cancer, Amenorrhea, Menstrual Cycle.

What interventions are being tested in trial NCT00589654?

The interventions under investigation include: Questionnaire (OTHER).

Who is sponsoring clinical trial NCT00589654?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00589654 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.